At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...
Wednesday, Lilly took another giant step in that endeavor, revealing that it will build a $4.5 billion R&D and manufacturing facility. Dubbed the Lilly Medicine Foundry, it will “drive ...